Workflow
业绩表现
icon
Search documents
【稳健医疗(300888.SZ)】Q1业绩表现亮眼,医疗和消费品板块协同发力——2024年年报及25年一季报点评(姜浩/朱洁宇)
光大证券研究· 2025-05-08 09:13
Core Viewpoint - The company reported a steady growth in revenue and net profit for 2024, with a significant increase in Q1 2025, indicating a positive trend in financial performance [3][4]. Financial Performance - In 2024, the company achieved a revenue of 8.98 billion yuan, a year-on-year increase of 9.7%, and a net profit attributable to shareholders of 700 million yuan, up 19.8% [3]. - For Q1 2025, the company reported a revenue of 2.61 billion yuan, representing a year-on-year growth of 36.5%, and a net profit of 250 million yuan, also up 36.3% [3]. Medical Consumables Segment - In 2024, the revenue from medical consumables accounted for 43.5% of total revenue, with a slight increase of 1.1% year-on-year. However, excluding the contribution from the acquired GRI, the revenue declined by 6.4% [4]. - The gross margin for medical consumables decreased by 3.9 percentage points to 36.5% in 2024, with a notable decline in the gross margin of infection protection products [4]. - In Q1 2025, the revenue from medical consumables surged by 46.3%, with a 10.5% growth when excluding GRI's impact [4]. Health and Lifestyle Products Segment - The health and lifestyle products segment accounted for 55.6% of total revenue in 2024, with a year-on-year growth of 17.1% and a slight decrease in gross margin by 1.0 percentage points [6]. - For Q1 2025, this segment's revenue grew by 28.8% year-on-year [6]. - Online and offline sales channels contributed to the revenue, with online sales growing by 18.9% and offline sales by 9.3% in 2024 [6][7]. Product Performance - In 2024, the revenue from infection protection products dropped significantly by 61.2%, while other product categories such as high-end wound dressings and surgical consumables showed strong growth [5]. - In Q1 2025, surgical consumables and high-end wound dressings experienced substantial growth rates of 196.8% and 21.1%, respectively [5].
“喜忧参半”的TCL
Bei Jing Shang Bao· 2025-05-05 13:00
Core Viewpoint - TCL has expanded its business beyond traditional home appliances into smart terminals and new energy sectors under the leadership of Li Dongsheng, with mixed financial results from its four listed companies in 2024 [1][3]. Group 1: Financial Performance of TCL Companies - TCL Technology reported a revenue of approximately 164.82 billion yuan in 2024, a decrease of 5.47% year-on-year, with a net profit of about 1.564 billion yuan, down 29.38% [3]. - The semiconductor display business of TCL Technology achieved a record revenue of 104.3 billion yuan in 2024, growing by 25% year-on-year, and a net profit of 6.23 billion yuan, an increase of 62.4% [3][5]. - TCL Zhonghuan, a subsidiary of TCL Technology, faced significant challenges, with a revenue of approximately 28.419 billion yuan in 2024, down 51.95%, and a net loss of about 9.818 billion yuan [4]. Group 2: Performance of Other TCL Subsidiaries - Tianjin Printers achieved a revenue of approximately 1.128 billion yuan in 2024, a year-on-year increase of 74.57%, with a net profit of about 33.8644 million yuan, up 28.16% [7]. - TCL Smart Home reported a revenue of approximately 18.361 billion yuan in 2024, a growth of 20.96%, and a net profit of about 1.019 billion yuan, an increase of 29.58% [7][8]. Group 3: Market Capitalization Trends - The total market capitalization of the four TCL companies was approximately 124.297 billion yuan, with TCL Technology leading at nearly 78 billion yuan [9]. - In 2025, the total market capitalization of these companies experienced a decline, with TCL Smart Home seeing the largest drop of over 20% [9].
卓越新能:2025年第一季度净利润6131.22万元,同比增长111.22%
news flash· 2025-04-18 09:40
卓越新能公告,2025年第一季度营收为7.09亿元,同比下降18.39%;净利润为6131.22万元,同比增长 111.22%。 ...